We also compared immune cell components in the tumors at day 21 post-E0771-GFP implantation and found that CD8+ T cell infiltration was reduced in the CLL-treated mice compared to PBS-L treated mice. Here, CD8A is linked to B-cell chronic lymphocytic leukemia.